The changing faces of EBV research.
D000818:Animals; D000956:Antigens, Viral / Q000235:genetics; D001402:B-Lymphocytes / Q000382:microbiology*; D002460:Cell Line; D002467:Cell Nucleus / Q000276:immunology; D002472:Cell Transformation, Viral; D002648:Child; D019309:Epstein-Barr Virus Nuclear Antigens; D005260:Female; D005814:Genes, Viral; D006566:Herpesviridae Infections / Q000382:microbiology*; D004854:Herpesvirus 4, Human / Q000235:genetics / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007244:Infectious Mononucleosis / Q000382:microbiology; D008213:Lymphocyte Activation; D008232:Lymphoproliferative Disorders / Q000382:microbiology; D008297:Male; D051379:Mice; D009303:Nasopharyngeal Neoplasms / Q000382:microbiology; D011991:Receptors, Virus / Q000378:metabolism; D014178:Translocation, Genetic; D014412:Tumor Virus Infections / Q000382:microbiology
D000956:Antigens, Viral; D019309:Epstein-Barr Virus Nuclear Antigens; D011991:Receptors, Virus